rs104894696

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_021175.4(HAMP):​c.212G>A​(p.Gly71Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,614,026 control chromosomes in the GnomAD database, including 5 homozygotes. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0027 ( 4 hom. )

Consequence

HAMP
NM_021175.4 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: -0.210

Publications

26 publications found
Variant links:
Genes affected
HAMP (HGNC:15598): (hepcidin antimicrobial peptide) The product encoded by this gene is involved in the maintenance of iron homeostasis, and it is necessary for the regulation of iron storage in macrophages, and for intestinal iron absorption. The preproprotein is post-translationally cleaved into mature peptides of 20, 22 and 25 amino acids, and these active peptides are rich in cysteines, which form intramolecular bonds that stabilize their beta-sheet structures. These peptides exhibit antimicrobial activity against bacteria and fungi. Mutations in this gene cause hemochromatosis type 2B, also known as juvenile hemochromatosis, a disease caused by severe iron overload that results in cardiomyopathy, cirrhosis, and endocrine failure. [provided by RefSeq, Oct 2014]
HAMP Gene-Disease associations (from GenCC):
  • hemochromatosis type 2B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hemochromatosis type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 19-35284999-G-A is Benign according to our data. Variant chr19-35284999-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 4286.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00183 (278/152294) while in subpopulation NFE AF = 0.00319 (217/68010). AF 95% confidence interval is 0.00284. There are 1 homozygotes in GnomAd4. There are 119 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HAMPNM_021175.4 linkc.212G>A p.Gly71Asp missense_variant Exon 3 of 3 ENST00000222304.5 NP_066998.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HAMPENST00000222304.5 linkc.212G>A p.Gly71Asp missense_variant Exon 3 of 3 1 NM_021175.4 ENSP00000222304.2
HAMPENST00000598398.5 linkc.212G>A p.Gly71Asp missense_variant Exon 4 of 4 2 ENSP00000471894.1
HAMPENST00000593580.1 linkn.2483G>A non_coding_transcript_exon_variant Exon 1 of 1 6
ENSG00000307628ENST00000827558.1 linkn.392-4126C>T intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.00183
AC:
278
AN:
152176
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00319
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00168
AC:
422
AN:
251490
AF XY:
0.00158
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00556
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00302
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00270
AC:
3949
AN:
1461732
Hom.:
4
Cov.:
31
AF XY:
0.00256
AC XY:
1859
AN XY:
727184
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33476
American (AMR)
AF:
0.000201
AC:
9
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00593
AC:
155
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86256
European-Finnish (FIN)
AF:
0.000468
AC:
25
AN:
53420
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00325
AC:
3609
AN:
1111862
Other (OTH)
AF:
0.00227
AC:
137
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
214
428
642
856
1070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00183
AC:
278
AN:
152294
Hom.:
1
Cov.:
31
AF XY:
0.00160
AC XY:
119
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41556
American (AMR)
AF:
0.000785
AC:
12
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00319
AC:
217
AN:
68010
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00249
Hom.:
1
Bravo
AF:
0.00175
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00279
AC:
24
ExAC
AF:
0.00203
AC:
246
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00284
EpiControl
AF:
0.00261

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Sep 15, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hereditary hemochromatosis Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

HAMP-related disorder Benign:1
Jun 09, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Hemochromatosis type 1 Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HAMP: BS1 -

Hemochromatosis type 2B Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Hemochromatosis, type 2a, modifier of Other:1
Sep 01, 2003
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
0.71
DANN
Benign
0.91
DEOGEN2
Uncertain
0.75
D;D
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.031
N
LIST_S2
Benign
0.69
.;T
M_CAP
Uncertain
0.088
D
MetaRNN
Uncertain
0.43
T;T
MetaSVM
Benign
-0.34
T
PhyloP100
-0.21
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-2.2
.;N
REVEL
Uncertain
0.57
Sift
Benign
0.23
.;T
Sift4G
Benign
0.17
T;T
Polyphen
0.44
B;B
Vest4
0.74
MVP
0.81
MPC
0.37
ClinPred
0.0090
T
GERP RS
-4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.23
gMVP
0.29
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104894696; hg19: chr19-35775902; COSMIC: COSV107292523; API